Health Populi July 11, 2019
The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses. Today’s example of this is Clover Health, which launched Clover Therapeutics this week. This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries.
“Clover Therapeutics was created to address the significant unmet needs in chronic progressive diseases in the Medicare population,” Cheng Zhang, Head of Clover Therapeutics, is quoted in the press release.
The company will first collaborate with Genentech (Roche) to research and develop therapies based on genomic factors that are risks for people developing diseases of the eye. The press release suggests that ocular diseases will be...